TP53 and thyroid gland carcinoma: These 85% of poorly differentiated thyroid carcinomas not only contain BRAFV600E or RAS mutations as found in well-differentiated carcinomas but also show additional mutations in the TERT promoter, TP53, PIK3CA pathway genes, and/or others [8, 16–20].